DataMeds AI settles shareholder litigation, pays $450,000 to repurchase 364,099 shares
MEDS•Payment terms and share repurchase
The company paid $450,000 total:
- $350,000 for the repurchase and extinguishment of 364,099 common shares
- $100,000 to settle released claims
Expected balance-sheet impact and dismissal
The settlement is expected to extinguish about $19 million of balance-sheet liability.
The cases are to be dismissed with prejudice, and the parties agreed to mutual releases.
Settlement resolves Florida and Delaware litigation
DataMeds AI entered a Sept. 11, 2026 settlement to end Florida state court litigation tied to a May 11, 2023 purchase agreement.
The deal also resolves a Delaware Chancery action filed by Brian Norton and other selling holders over consideration, obligations, and common stock.
